Zhengye Biotechnology Holding Ltd (ZYBT) stock
ZYBTNasdaqPharmaceutical Preparations
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$1.50−0.02 (-1.32%)
Close on Nov 18, 2026Market cap $71.09MP/E –Yield –
Zhengye Biotechnology price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Zhengye Biotechnology's price to sales ratio was 4.1× on Nov 11, 2026, against 3.6× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 4.1× | +2.2 |
| 2025 | Dec 31, 2025 | 2.0× | – |
See a number that looks wrong?